A detailed history of Humankind Investments LLC transactions in Biogen Inc. stock. As of the latest transaction made, Humankind Investments LLC holds 2,271 shares of BIIB stock, worth $338,424. This represents 0.16% of its overall portfolio holdings.

Number of Shares
2,271
Previous 1,904 19.28%
Holding current value
$338,424
Previous $441,000 0.23%
% of portfolio
0.16%
Previous 0.12%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$189.07 - $236.8 $69,388 - $86,905
367 Added 19.28%
2,271 $440,000
Q2 2024

Aug 12, 2024

SELL
$190.52 - $236.72 $53,917 - $66,991
-283 Reduced 12.94%
1,904 $441,000
Q1 2024

May 08, 2024

BUY
$212.02 - $267.71 $52,368 - $66,124
247 Added 12.73%
2,187 $471,000
Q4 2023

Feb 14, 2024

BUY
$222.59 - $267.94 $77,016 - $92,707
346 Added 21.71%
1,940 $502,000
Q3 2023

Nov 13, 2023

BUY
$253.3 - $285.89 $58,512 - $66,040
231 Added 16.95%
1,594 $409,000
Q2 2023

Aug 09, 2023

SELL
$275.25 - $318.06 $232,311 - $268,442
-844 Reduced 38.24%
1,363 $388,000
Q1 2023

Apr 25, 2023

BUY
$256.56 - $292.34 $47,720 - $54,375
186 Added 9.2%
2,207 $613,000
Q4 2022

Jan 26, 2023

SELL
$252.44 - $306.72 $209,020 - $253,964
-828 Reduced 29.06%
2,021 $0
Q3 2022

Nov 09, 2022

BUY
$194.69 - $268.46 $54,902 - $75,705
282 Added 10.99%
2,849 $761,000
Q2 2022

Aug 05, 2022

BUY
$187.54 - $223.02 $6,751 - $8,028
36 Added 1.42%
2,567 $524,000
Q1 2022

May 09, 2022

BUY
$193.77 - $244.14 $107,736 - $135,741
556 Added 28.15%
2,531 $533,000
Q4 2021

Mar 21, 2022

BUY
$223.92 - $287.77 $142,637 - $183,309
637 Added 47.61%
1,975 $474,000
Q3 2021

Mar 21, 2022

BUY
$282.99 - $369.05 $20,375 - $26,571
72 Added 5.69%
1,338 $379,000
Q2 2021

Mar 21, 2022

BUY
$259.0 - $414.71 $110,075 - $176,251
425 Added 50.54%
1,266 $438,000
Q1 2021

Mar 21, 2022

BUY
$242.95 - $284.63 $204,320 - $239,373
841 New
841 $235,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Humankind Investments LLC Portfolio

Follow Humankind Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Humankind Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Humankind Investments LLC with notifications on news.